Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression
Clinical trial NCT00944047 · COMPLETED
Trial details
- NCT number
- NCT00944047
- Sponsor
- University of Kansas Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2014-05-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.